Loading...
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
The use of chemotherapy in premenopausal cancer patients may lead to chemotherapy-induced premature ovarian failure. Pharmacological temporary ovarian suppression obtained with the gonadotropin-releasing hormone agonist (GnRHa) administered concomitantly with chemotherapy has been investigated as a...
Na minha lista:
Udgivet i: | Clin Med Insights Reprod Health |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
SAGE Publications
2019
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6669835/ https://ncbi.nlm.nih.gov/pubmed/31391786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179558119864584 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|